IL-25 promotes hepatic macrophage differentiation towards the M2a phenotype, both in vivo and in vitro, via the IL-13/STAT6 pathway, alleviating HFD-induced hepatic steatosis (Zheng et al., 2019). The gene discussed is STAT6; the disease is Hepatic steatosis.